In response [6]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 3, 2006, Pages

  Feinbloom, David ^a   Bauer, Kenneth A ^a  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ARTERY THROMBOSIS; CELL DAMAGE; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; LETTER; PRIORITY JOURNAL; RISK FACTOR; BLOOD; HEMOSTASIS; NOTE; PHYSIOLOGY; PREDICTION AND FORECASTING; THROMBOSIS;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; HEMOSTASIS; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; THROMBOSIS;

EID: 33646832071     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000204348.87254.cc     Document Type: Letter

References (3)

1. Feinbloom D, Bauer K. Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol. 2005;25:2043-2053.
2. Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Juhan-Vague I, on behalf of the PRIME Study Group. Endothelial cell markers and the risk of coronary heart disease: The prospective epidemiological study of myocardial infarction (PRIME) study. Circulation. 2004;109:1343-1348.
3. Lee KW, Lip GYH, Tayebjee M, Foster W, Blann AD. Circulating endothelial cells, von Willebrand factor, interleukin (IL)-6, and prognosis in patients with acute coronary syndromes. Blood. 2005;105:526-532.